Induction of interleukin 8 release from the HMC-1 mast cell line: synergy between stem cell factor and activators of the adenosine A(2b) receptor

• Published in: Biochemical pharmacology 2002-07, Vol.64 (2), p.317-325
• Main Authors: Meade, Christopher J, Worrall, Liam, Hayes, Dawn, Protin, Ursula
• Format: Article
• Language: English
• Subjects: Adenosine-5'-(N-ethylcarboxamide) - pharmacology; Cells, Cultured; Humans; Interleukin-8 - metabolism; Mast Cells - metabolism; Purinergic P1 Receptor Agonists; Receptor, Adenosine A2B; Stem Cell Factor - metabolism
• ISSN: 0006-2952
• DOI: 10.1016/S0006-2952(02)01058-4

The HMC-1 mast cell line has both adenosine A(3) and A(2b) receptors on its surface, but only agonists of the A(2b) receptor are effective at releasing interleukin 8. Object of this study was to look for co-factors for adenosine A(2b) receptor activation. There was a powerful and statistically significant synergy for release of IL-8, both at the mRNA level (measured after 4 hr) and protein level (measured after 24 hr), between adenosine A(2b) receptor agonists and stem cell factor (SCF). Suitable concentrations for showing synergy were 100 ng/mL SCF and 3 microM 5'-N-ethylcarboxamidoadenosine (NECA). At these concentrations, the IL-8 released into the culture medium after SCF and NECA together was typically 3-5-fold greater in amount than the sum of the amounts of IL-8 released after exposure to the same concentrations of NECA and SCF separately. Since mast cells may be exposed to both adenosine and stem cell factor in the diseased lung, the synergy observed in this model system may have implications for asthma.